Actively Recruiting
Studying Health Outcomes After Treatment in Patients With Retinoblastoma
Led by Vanderbilt-Ingram Cancer Center · Updated on 2025-09-19
900
Participants Needed
11
Research Sites
622 weeks
Total Duration
On this page
Sponsors
V
Vanderbilt-Ingram Cancer Center
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This trial studies health outcomes after treatment in patients with retinoblastoma. Gathering health information over time from patients and family members through vision assessments, samples of tissue and saliva, and questionnaires may help doctors learn more about what causes retinoblastoma, identify long-term health outcomes for patients with retinoblastoma, and find out which therapies may be the best for treating retinoblastoma
CONDITIONS
Official Title
Studying Health Outcomes After Treatment in Patients With Retinoblastoma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Unilateral or bilateral intraocular retinoblastoma
- Diagnosis between the ages of 0 to 17.99 years
- Diagnosis on or after January 1, 2008
- No exclusions based on primary or secondary treatment modalities
- Retrospective group patients must be 6 months post end of treatment at study entry
- Prospective group patients must not have begun treatment
- Patients must be able to communicate in English, French, or Spanish
- One sibling not affected by retinoblastoma will be enrolled, preferably closest in age to the patient
- All patients and/or their parents or legal guardians must sign a written informed consent
- All institutional, FDA, and NCI requirements for human studies must be met
You will not qualify if you...
- Patients with diminished capacity will not be enrolled
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 11 locations
1
Lurie Children's Hospital
Chicago, Illinois, United States, 60611
Actively Recruiting
2
University of Illinois, Chicago
Chicago, Illinois, United States, 60612
Actively Recruiting
3
University of Minnesoa
Minneapolis, Minnesota, United States, 55455
Actively Recruiting
4
Washington School of Medicine at St. Louis
St Louis, Missouri, United States, 63110
Actively Recruiting
5
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States, 45229
Actively Recruiting
6
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States, 19104
Actively Recruiting
7
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States, 37232
Actively Recruiting
8
MD Anderson Cancer Center
Houston, Texas, United States, 77030
Actively Recruiting
9
Texas Childeren's Hospital
Houston, Texas, United States, 77030
Actively Recruiting
10
Children's Hospital of Wisconsin
Milwaukee, Wisconsin, United States, 53226
Actively Recruiting
11
The Hosptial for Sick Children
Toronto, Canada
Actively Recruiting
Research Team
V
Vanderbilt-Ingram Service for Timely Access
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here